key: cord-1003409-ys8cwfj4
authors: Kaur, Shagun; Campbell, Stephanie L.; Stockton, David W.
title: Management of COVID‐19 infection in organic acidemias
date: 2021-03-08
journal: Am J Med Genet A
DOI: 10.1002/ajmg.a.62161
sha: b21f69bf292cf2e1263c955ffbb979fbfe896d2f
doc_id: 1003409
cord_uid: ys8cwfj4

The COVID‐19 pandemic has affected the health and healthcare of individuals of all ages worldwide. There have been multiple reports and reviews documenting a milder effect and decreased morbidity and mortality in the pediatric population, but there have only been a small number of reports discussing the SARS‐CoV‐2 infection in the setting of an inborn error of metabolism (IEM). Here, we report two patients with underlying metabolic disorders, propionic acidemia and glutaric aciduria type 1, and discuss their clinical presentation, as well as their infectious and metabolic management. Our report demonstrates that individuals with an underlying IEM are at risk of metabolic decompensation in the setting of a COVID‐19 infection. The SARS‐CoV‐2 virus does not appear to cause a more severe metabolic deterioration than is typical.

To date, there have been very few published reports of COVID-19 infection in patients with a known inborn error of metabolism (IEM). Patients with IEMs are at a high risk for metabolic decompensation in the setting of any infection due to catabolic shift in the body's metabolism. The Centers for Disease Control and Prevention (CDC) suggests that this patient population may be at a high risk for severe illness due to and therefore should take extra precautions. Most families with a child with an IEM have been advised to take precautions to avoid exposure, and to respond to an acute illness per usual with an emergency room (ER) protocol. It was not known whether pediatric patients with inborn errors of metabolism would have mild symptomatology similar to the general pediatric population, or if they could have more severe symptoms due to their underlying IEM in addition to metabolic decompensation. Here, we report our center's first known patients with an established diagnosis of an IEM and an acute illness due to COVID-19.

propionic acidemia ER protocol, and was immediately started on dextrose 10% fluids at 1.5 times maintenance fluid rate. Her initial lab work is shown in Table 1 and was significant for an anion gap metabolic acidosis, ketonuria, mild elevation of ammonia, pancytopenia, a prolonged PTT, elevated ferritin, elevated D-dimer, and normal CRP.

She was started on ceftriaxone, in the setting of an indwelling port and febrile neutropenia. She had prolonged capillary refill and was hypotensive to 40/20 mmHg, which was concerning for septic shock.

A normal saline bolus was given and she was started on a dopamine drip. She received respiratory support with high flow oxygen via nasal cannula. Her GJ-tube feeds were adjusted to have 50% reduced natural protein, while providing a total of 140% of her calculated weight based daily caloric needs. Her home metabolic medications were continued. She was admitted to the pediatric intensive care unit (PICU) for further care. Antibiotics were escalated to cefepime and vancomycin, but discontinued after blood cultures were negative for 48 hours and symptoms were attributed to her SARS-CoV-2 infection. Final results for cultures were also negative. Blood pressures improved after fluid resuscitation and the dopamine drip was discontinued. Oxygen support was also weaned off within 24 hours. While receiving fluids with a high glucose infusion rate, she developed hyperglycemia with lactic acidosis. An insulin drip was started, but she developed insulin resistance, which has occurred with some of her previous decompensations, so the caloric source was transitioned to full feeds and intravenous (IV) intralipids.

Pancytopenia was noted, which is known to be a feature of PA, but could also be secondary to the acute SARS-CoV-2 infection (Baumgartner et al., 2014) . She required two platelet transfusions and one packed red cell transfusion. A head ultrasound was obtained due to thrombocytopenia and concern for hemorrhage. It showed increased echotexture in the bilateral thalami and caudate nuclei. These were new findings compared to her last head ultrasound 6 months prior. Findings were to be followed on a brain MRI at a future date.

The infectious disease team was consulted due to concern for Multisystem Inflammatory Syndrome in Children (MIS-C) in the setting of a COVID-19 positive status with lactic acidosis, elevated inflammatory markers, and labile blood pressures. It was unclear if these abnormalities were caused solely by her underlying propionic acidemia or if she was also developing MIS-C due to a COVID-19 infection. IV immunoglobulin and aspirin were to be considered if cardiac abnormalities were detected; however, an echocardiogram was obtained and was unremarkable with no signs of coronary vessel involvement. IV remdesivir was also under consideration, to be used if there was respiratory decompensation, but was not required.

With increased caloric intake, the metabolic derangements resolved, and her clinical condition improved. She was eventually transitioned back to her outpatient feeds and medications, and discharged home with no known long-term sequelae from this acute decompensation secondary to COVID-19. Prior to discharge, all of her laboratory abnormalities resolved with the exception of persistent anemia, which was thought to be iatrogenic. She had an 8-day hospital course, seven of which were spent in the PICU.

She did follow-up with cardiology 2 months after discharge, at which time her cardiac exam, electrocardiogram, and echocardiogram were unremarkable. There is also another condition associated with COVID-19 that has been reported in the pediatric population, known as Multisystem Inflammatory Syndrome in Children (MIS-C), typically associated with elevations of inflammatory markers such as ferritin, LDH, and CPK.

Myocarditis, coagulopathy and end organ damage have all been reported in association with MIS-C. As of October 30, 2020 there

Children and COVID-19: State Data Report

Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia

SARS-CoV-2-associated deaths among persons aged <21 years -United States

SARS-CoV-2 infection in a patient with propionic acidemia

Department of Health & Human Services

Epidemiology of COVID-19 among children in China

Characteristics and outcomes of coronavirus infection in children: The role of viral factors and an immunocompromised state